UltraSeal XT Plus Clear Refill. The package contains 4x 1.2 ml UltraSeal XT Plus. Product Usa...
FDA Device Recall #Z-0704-2017 — Class II — November 17, 2016
Recall Summary
| Recall Number | Z-0704-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 17, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ultradent Products, Inc. |
| Location | South Jordan, UT |
| Product Type | Devices |
| Quantity | 31 |
Product Description
UltraSeal XT Plus Clear Refill. The package contains 4x 1.2 ml UltraSeal XT Plus. Product Usage: The UltraSeal XT Plus is used for prophylactic sealing of pits and fissures. It may also be used for micro restorative or initial layer of composite restorations.
Reason for Recall
There was a labeling error with product, UltraSeal XT Plus Clear Refill, Part Number (PN) 565, Lot Number (Lot) BD79T. The package was mislabeled as PQ1, PN 641; while the barcode, IFU and products were labeled for UltraSeal XT Plus Clear Refill, PN 565, Lot BD79T.
Distribution Pattern
Worldwide Distribution - US Nationwide
Lot / Code Information
Lot BD79T
Other Recalls from Ultradent Products, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-3067-2024 | Class II | Brand Name: Transcend Product Name: Transcend ... | Aug 2, 2024 |
| Z-3068-2024 | Class II | Brand Name: Transcend Product Name: Transcend ... | Aug 2, 2024 |
| Z-3066-2024 | Class II | Brand Name: Vit-l-escence Product Name: Vit-l-... | Aug 2, 2024 |
| Z-1368-2022 | Class II | Peak Universal Bond Self-Etch Bottle Kit, Part:... | Jun 1, 2022 |
| Z-0053-2021 | Class II | PermaFlo Flowable Composite REF-UP 948 Shade: A... | Aug 31, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.